EpiBone
PrivateLast Round
Convertible Debt
Nov 8, 2024
Total Funding Raised
$60.71M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EpiBone operates in Healthcare & Life Sciences and is based in Jersey City, New Jersey. Its latest recorded funding round was a Convertible Debt round in November 2024.
EpiBone is a biotechnology company that develops personalized, living bone and cartilage grafts using a patient's own stem cells and 3D-printed scaffolds for skeletal reconstruction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiBone Comparables
Compare EpiBone with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonus Biogroup | 84% | |
| Novadip Biosciences | 83% | |
| Ocugen | 78% |
For institutional investors. Book with your work email.
EpiBone Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Nov 8, 2024 | ||||
| Grant | Aug 16, 2024 | ||||
| Series B | Sep 20, 2023 | ||||
| Series B | Dec 27, 2022 | ||||
| Series B Extension | Nov 26, 2021 | ||||
Debt | Feb 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EpiBone Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kendall Capital Partners | Convertible Debt, Series B |
| United States Department of Defense | Grant |
| Thiel Foundation | VC Round, Grant, Seed |
| Plum Alley Investments | VC Round |
| Tech Council Ventures | VC Round |
| Breakout Ventures | VC Round, Grant |
| Alexandria Venture Investments | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 42% MoM, reaching 4.3K.
- Nov 8, 2024
Kendall Capital Partners led the round.
For institutional investors. Book with your work email.
EpiBone Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EpiBone's valuation, stock price, and market status.
Is EpiBone a public or private company?
EpiBone is a private company.
What is the current stock price of EpiBone?
EpiBone is a private company, so its shares have no public market price. Caplight tracks EpiBone's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EpiBone worth (valuation)?
Valuation information for EpiBone is not publicly available.
Can I buy EpiBone stock?
EpiBone shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EpiBone's last funding round?
EpiBone's most recent funding round was Convertible Debt on November 8, 2024.
Who are the main investors in EpiBone?
Key investors in EpiBone include Kendall Capital Partners, Tech Council Ventures, Breakout Ventures.
Will EpiBone IPO soon?
No public IPO plans have been announced for EpiBone.
How can I track EpiBone secondary market activity?
Caplight tracks bids, offers, and trades in EpiBone's shares on secondary markets.